GGrantIndex
Sort

78,016 grants matching breast cancer

Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis

$840,327
Brian L Sprague · University Of Vermont & St Agric College · R01 · FY2023 · CA

MINORITY-BASED COMMUNITY ONCOLOGY PROGRAM

$840,151
Balazs Halmos · Montefiore Medical Center (Bronx, Ny) · UG1 · FY2021 · CA

COMMUNITY CLINICAL ONCOLOGY PROGRAM

$840,071
Via Christi Regional Medical Center · U10 · FY2000 · CA

Biomarker-Based Phase IIB Trial of (Bazedoxifene-Conjugated Estrogen) to Reduce Risk for Breast Cancer

$840,045
Carol J Fabian · University Of Kansas Medical Center · R01 · FY2022 · CA

Genetic Epidemiology

$839,884
Alisa Goldstein · Division Of Cancer Epidemiology And Genetics · ZIA · FY2018 · CA

DAMAGED PROGENITORS AS TARGETS FOR BREAST CANCER PREVENTION

$839,856
The General Hospital Corporation · · FY2019 · Department of the Army

Association of Nutritional and Biochemical Predictors of Body Fat Amount and Distribution with Cancer Risk

$839,461
Unhee Lim · University Of Hawaii At Manoa · P01 · FY2015 · CA

Cancer Mortality among Military Participants at U.S. Nuclear Weapons Tests

$839,275
John Dunning Boice · Vanderbilt University · U01 · FY2010 · CA

TGF-betas in breast cancer progression

$839,111
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Development of TGF-beta antagonists for cancer therapy

$839,111
Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Functionally Validated Lentiviral siRNA libraries

$839,064
Alex Chenchik · Cellecta, Inc. · R44 · FY2010 · RR

Development of TIMP-2 derivatives or strategies as biologic therapies for cancer

$838,914
William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Cancer Deep Phenotype Extraction from Electronic Medical Records

$838,821
Guergana K. Savova · Boston Children'S Hospital · U24 · FY2022 · CA

Cancer Deep Phenotype Extraction from Electronic Medical Records

$838,819
Guergana K. Savova · Boston Children'S Hospital · U24 · FY2023 · CA

A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy

$838,708
Cohava Gelber · Serpin Pharma, Llc · R44 · FY2024 · CA

A Stakeholder Informed Randomized Trial of Pretest Video Education vs Standard Genetic Counseling for Cancer Patients: Evaluating the Impact on Patients, Providers and Practices

$838,005
Huma Q Rana · Dana-Farber Cancer Inst · R01 · FY2022 · HG

Mechanism of action and therapeutic utility of stimulatory CpG oligonucleotides

$837,803
Dennis Klinman · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Mouse Models of Human Breast Cancer

$837,723
Jeffrey Rosen · Baylor College Of Medicine · U01 · FY2006 · CA

Biological Functions of Chromosomal Proteins

$837,688
Michael Bustin · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA

Engineering Multifunctional Nanoparticles

$837,291
Sangeeta N. Bhatia · Massachusetts Institute Of Technology · R01 · FY2007 · CA

Hawaii Minority-Based Clinical Community Oncology Program

$837,264
Jeffrey Lee Berenberg · University Of Hawaii At Manoa · U10 · FY2010 · CA

Risk prediction methods

$837,241
Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA

Mammary Tumorigenesis in Inbred and Feral Mice

$837,206
Robert Callahan · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Older Breast Cancer Patients: Risk For Cognitive Decline

$836,998
Jeanne Mandelblatt · Georgetown University · R01 · FY2016 · CA

Epidemiology and Genomics of Health Disparities

$836,990
Anna Maria Napoles · National Institute On Minority Health And Health Disparities · ZIA · FY2019 · MD